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The universality of peptidoglycan in bacteria underlies the broad spectrum of many suc-
cessful antibiotics. However, in our times of widespread resistance, the diversity of pepti-
doglycan modifications offers a variety of new antibacterials targets. In some Gram-positive
species such as Streptococcus pneumoniae, Staphylococcus aureus, or Mycobacterium tubercu-
losis, the second residue of the peptidoglycan precursor, D-glutamate, is amidated into iso-D-
glutamine by the essential amidotransferase MurT/GatD complex. Here, we present the
structure of this complex at 3.0 Å resolution. MurT has central and C-terminal domains
similar to Mur ligases with a cysteine-rich insertion, which probably binds zinc, contributing
to the interface with GatD. The mechanism of amidation by MurT is likely similar to the
condensation catalyzed by Mur ligases. GatD is a glutaminase providing ammonia that is
likely channeled to the MurT active site through a cavity network. The structure and assay
presented here constitute a knowledge base for future drug development studies.
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Peptidoglycan is a defining trait of bacteria and its metabo-lism is targeted by major antibiotics. A mesh-polymer thatsurrounds the cell, defining its shape and providing resis-
tance to osmotic pressure, peptidoglycan is extraordinarily con-
served, consisting of chains of alternating N-acetylglucosamine
(GlcNAc) and N-acetylmuramic acid (MurNAc) that are cross-
linked by peptide bridges attached to the MurNAc1.
On the other hand, peptidoglycan is also very diverse. Pepti-
doglycan is thin and mono-layered, or thick and multi-layered, in
Gram-negative or Gram-positive bacteria. Chain length ranges
from a few units (Staphylococcus aureus) to several hundred
(Bacilli), with reducing ends or terminating with 1,6-anhy-
droMurNAc. Glycan chains are modified by various degrees of N-
deacetylation, and O-acetylation and N-glycolylation1.
The peptide component shows even greater variety arising
from the diverse residues assembled into the precursor penta-
peptide by the Mur ligases C, D, E, and F1. The first residue is
generally an L-Ala, but can be Gly or L-Ser. The second amino
acid is D-Glu. The third residue attached to the C5 of the D-Glu
can be L-Lys, as in Streptococcus pneumoniae, or a meso-diami-
nopimelate, as in many Gram-negative species, or a variety of
other residues. The fourth and fifth residues, added as dipeptide,
is generally D-Ala-D-Ala, but can be D-Ala-D-Ser or D-Ala-D-
lactate.
Peptide cross-linking and maturation at the cell surface can
also differ. The D,D-transpeptidase activity of the penicillin-
binding proteins (PBPs) forms the most common 3–4 linkage
with or without intervening branches. PBPs are also responsible
in some Corynebacteria for the 2–4 linkage with an intermediate
diamino acid. L,D-transpeptidases can form 3–3 linkages in many
species, and account for most of the cross-linking in Myco-
bacteria, Clostridia, and in some β-lactam-resistant bacteria. The
fifth and fourth residues can be trimmed by carboxypeptidases.
The degree of cross-linking and trimming is variable1.
The modification of the precursor peptide in the cytoplasm
provides additional diversity. Amino acids can be added on the
second or third residue to form branches, such as the pentagly-
cine in S. aureus, and the L-Ala-L-Ala or L-Ser-L-Ala in
S. pneumoniae. These branches are generally part of the cross-
links. The meso-diaminopimelate is amidated in some species
such as Bacillus subtilis. At the second position, the D-glutamate
can be amidated into D-iso-glutamine in many Gram-positive
organisms by the MurT/GatD amidotransferase complex that is
the subject of our study.
MurT/GatD amidates the C1 carboxylate of the D-Glu to form
a D-iso-Gln at the second position of the membrane-bound
peptidoglycan precursor lipid II (Fig. 1). This activity was long
known in S. aureus extract2, but the responsible operon (murT-
gatD) was identified only recently3,4. MurT is homologous to the
Mur ligases that elongate the peptide of the UDP-linked soluble
precursors5–8. GatD belongs to the class I glutaminase with a
characteristic catalytic Cys-His-Asp/Glu triad, and is homologous
to the glutaminase domain of a variety of amidotransferases such
as cobyric acid synthase, CTP synthetase, or imidazole glycerol
phosphate (IGP) synthase9. GatD is thought to hydrolyze L-
glutamine to generate ammonia, which is used by MurT to
amidate lipid II. By analogy with reactions catalyzed by Mur
ligases, the acceptor carboxyl of the D-Glu is thought to be
activated by phosphorylation10.
In vitro, MurT/GatD from S. aureus was shown to amidate
both lipid II and its immediate precursor lipid I, which lacks
GlcNAc, but none of the soluble UDP-linked precursors4. L-Gln
is the nitrogen donor in neutral and basic conditions (pH 7.5 and
8.5). Ammonia could also serve as direct nitrogen source at pH
8.5, which is consistent with the mechanism of glutamine ami-
dotransferases, where ammonia is transferred to the synthase
subunit9. When ammonia was provided directly, amidation still
required presence of GatD4. Amidated lipid II was shown to be
the preferred substrate for transpeptidation by PBPs from S.
pneumoniae11.
In the quest for novel antibacterial target, MurT/GatD is par-
ticularly important due to its presence in mycobacteria, staphy-
lococci, enterococci, and streptococci. The essentiality of
murTgatD has been demonstrated in important pathogens such
as Mycobacterium tuberculosis12, S. pneumoniae11,13,14, and S.
aureus4,15,16. MurT/GatD depletion in S. aureus caused increased
susceptibility to β-lactams and lysozyme, including in methicillin-
resistant strains3,17.
β-Lactams antibiotics have been so successful due to their large
spectrum as they inhibit the D,D-transpeptidases that cross-link
peptidoglycan, a nearly universal feature. However, drugs with
narrower spectra are highly desirable. The diversity of the pep-
tidoglycan offers such opportunities. In this context, we present
the structure of a MurT/GatD complex, from the human
pathogen S. pneumoniae. The structure show that MurT is similar
to Mur ligases with a cysteine-rich insertion contributing to the
interface with GatD. Amidation probably proceeds like the con-
densation catalyzed by Mur ligases. GatD is a glutaminase pro-
viding ammonia that is likely channeled to the acceptor site
through a cavity network. This work, which reveals atomic details
of the active sites and interface, provides essential knowledge for
future efforts to design inhibitory molecules.
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Fig. 1 Proposed reaction scheme of the lipid II amidation by MurT/GatD. The second residue of the pentapeptide is highlighted in pink (D-Glu) or blue (D-
iso-Gln). The putative phosphorylated intermediate is also shown
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Results
Distribution of the murTgatD operon. We searched available
sequences to evaluate the distribution of murTgatD among bac-
teria. The operon is present in many Gram-positive bacteria of
the Terrabacteria superphylum, it is universally present in the
Actinobacteria and Chloroflexi, including in genera Cor-
ynabacterium, Mycobacterium, and Streptomyces. Among Firmi-
cutes, murTgatD is present in the whole Lactobacillales order that
includes genera: Streptococcus, Enterococcus, Lactococcus, Lacto-
bacillus; it is widespread in the Clostridiales, including in the
Clostridia. In Bacillales, murTgatD is ubiquitous in Staphylo-
coccaceae, but is nearly absent from Bacillaceae or Listeriaceae.
The operon is also ubiquitous in some classes of Cyanobacteria. A
few strains from Gram-negative species also contain the operon
suggesting gene transfer events.
Depletion of MurT/GatD. To investigate the function of
murTgatD in S. pneumoniae R6, an ectopic copy under the
control of the inducible promoter PcomX was introduced and the
endogenous copy was deleted. Growth of the resulting strain
required the presence of the ComS inducer, confirming the
essentiality of MurT/GatD. Depletion of MurT/GatD with
reduced concentrations of inducer caused aberrant morphologies
(Supplementary Fig. 1). Mild depletion (2.5 nM ComS) resulted
in some elongated cells with aborted septa, whereas severe
depletion (1.5 nM ComS) produced a high proportion of aberrant
cells, elongated or bulging, showing that proper cell wall assembly
requires a functioning murTgatD operon, as observed previously
with strain D3913.
The effect of MurT/GatD depletion on peptidoglycan compo-
sition was examined after the growth was stunted by the lack of
inducer, which occurred at OD550 ≈ 0.4 (Supplementary Table 1).
As expected, the proportion of (Glu)-muropeptides increased
from 18 to 42% upon depletion of MurT/GatD, indicating that a
minimal amount of around 58% amidated muropeptide is
required for growth. The proportion of cross-linked muropep-
tides decreased from 47 to 36%, which was also expected as
efficient cross-linking depends on the presence of iso-Gln11.
Surprisingly, there was an increase in the proportion of branched
muropeptides from 16 to 57%. As branching depends on the
MurM enzyme, a strain was constructed by deleting murM in the
MurT/GatD depletion strain. In this strain without branched
muropeptide, depletion of MurT/GatD caused a similar increase
of (Glu)-muropeptides and decrease of cross-linking.
In vitro enzymatic activity. A continuous assay was set up for the
future evaluation of potential inhibitors. MurT/GatD utilizes
three reactants: L-Gln, ATP, and (Glu)-lipid II; and generates
four products: L-Glu, ADP, phosphate, and (iGln)-lipid II
(Fig. 1). An ATPase assay was chosen, monitoring the generation
of ADP with coupled reactions that consumes NADH, which can
be quantified by its absorbance18. Comparable kinetics were
observed when aliquots withdrawn after various time intervals
were analyzed by thin layer chromatography (Supplementary
Fig. 2). The identity of the two lipid II species was checked by
mass spectrometry (Supplementary Fig. 2). Although all enzymes
and reactants are soluble in water, including lipid II (Supple-
mentary Fig. 2), no activity was detected without detergent. It is
presumed that lipid II forms micelles (Supplementary Fig. 2), and
that tight packing of the muropeptide heads hinders access to the
enzyme. With 25 μM lipid II, the enzymatic activity was optimal
with n-dodecyl-β-D-maltoside (DDM) at concentrations between
5 and 30 mM. A DDM concentration of 20 mM (150-fold the
critical micelle concentration) was chosen to ensure a micelle
concentration superior to that of lipid II.
Apparent KM was obtained for the three substrates, and kcat
was measured with lipid II (Table 1, Fig. 2). The apparent KM for
lipid II is in the range of values reported for Mur ligases and their
UDP-linked substrates (e.g., 5 and 90 μM for MurD and C6,19).
Turnover is similar to values measured with Mur ligases (e.g., 1 to
15 s−1 for MurD20,21). Due to the limited availability of lipid II,
we used a concentration below its apparent KM to measure the
dependence of kinetics on the concentrations of L-Gln or ATP.
Assuming that MurT has a mechanism similar to other Mur
ligases with an ordered binding of the substrates prior to products
release22,23, these measurements allow the estimation of the
apparent KM for ATP and L-Gln. An additional assumption is
that GatD is not limiting. The KM for ATP is in the lower range of
values for Mur ligases (e.g., 17 and 100 μM for MurE and C6,24).
The KM for L-Gln is one order of magnitude lower than reported
for other amidotransferases such as the IGP synthase25.
Overall structures of MurT and GatD. Despite the limited
resolution (3.0 Å, statistics in Supplementary Table 2), the elec-
tron density map allowed us to trace the main chains of all four
complexes in the asymmetric unit, revealing a triangular complex
with a large interface area adjacent to the enzymatic cavities of
MurT and GatD (Fig. 3a). The N-terminal region (1–42) of MurT
was not visible although its presence was confirmed by mass
spectrometry, indicating that this short segment is mobile. The
central (43–302) and C-terminal (303–439) domains are char-
acteristic of the Mur ligases26 (Fig. 3b, c and Supplementary
Fig. 3). The enzymatic cavity is nestled between the two domains,
with a large solvent-accessible area and one side contacting GatD
(Fig. 3a).
The central domain of MurT superimposes to those of Mur
ligases with r.m.s.ds (root-mean-square deviations) of 2.9–3.1 Å
over 116–119 residues (shown with Mur C in Supplementary
Fig. 3). It consists of a six-stranded parallel β-sheet (β2β3β1β4β5β6)
sandwiched between α-helices α2, α3, α4 on one side and a three-
helix bundle (α1α5α6) on the other side, flanked by a three-
stranded antiparallel β-sheet (β11β13β12) (Fig. 3b). In Mur ligases,
α-helices α2, α3, α4 (α5, 3/10-helix η3 and α7in MurC) are flanked
by a fourth helix (α8, Supplementary Fig. 3) that is not formed in
MurT, as the corresponding segment (169–177) contains two
prolines. The central domain forms a mononucleotide-binding
domain including a typical P-loop (Walker A motif GxxGK)27.
Residues 137–141 are not resolved in crystal structure. This loop
may form a mobile bridge extending towards the C-terminal
domain over the GatD active site. The most striking difference
between the central domain of MurT and those of Mur ligases is
the insertion of a cysteine-rich region (187–236) between β6 and
β11 (Fig. 3b). This region will be further presented below.
The C-terminal domain of MurT consists of a six-stranded β-
sheet (β14β15β19β16β17β18) surrounded by four helices on one side
(α7, η7, η8, and α8) and two on the other side (α9 and α10)
Table 1 MurT/GatD enzymatic parameters
Initial velocities method Progress curves global fit
Apparent KM
(μM)
kcat
(s−1)a
Apparent KD
(μM)
kcat
(s−1)
Lipid II 220 ± 60 4 ± 1 193 ± 3 5.0 ± 0.5
ATP 16 ± 2
L-Gln 78 ± 8
ATPase activity was determined by measuring the generation of ADP with a coupled enzymatic
assay at 30 °C and pH 7.5 with 1% DDM (w/v). Standard error is given
akcat= Vmax/[MurT/GatD]
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(Fig. 3c). Helices α8 and η7 interact with GatD. This domain
forms a Rossmann fold28 that superimposes onto those of Mur
ligases with r.m.s.ds of 2.9–3.4 Å over 129–159 residues (shown
with MurC in Supplementary Fig. 3).
The structure of GatD from pneumococcus is similar to that
from S. aureus (PDB# 5N9M; r.m.s.d. of 1.7 Å over 213 residues)
and to other class I glutaminases, such as the HisH subunit of IGP
synthase from Thermotoga maritima (PDB# 1GPW; r.m.s.d. of
2.9 Å over 190 residues) (Supplementary Fig. 4). It consists of a
seven-stranded β-sheet (β1β3β2β4β5β15β14) surrounded by three
α-helices on one side (α2, α3, α4) and four on the other side (α1,
α5, α6, α7), and flanked by two four-stranded β-sheets (β7β6β8β11
and β10β9β12β13) (Fig. 4a). A notable difference between
pneumococcal and staphylococcal proteins is the presence of a
long C-terminal α7 in S. aureus, whereas this region mainly forms
a contorted loop in the S. pneumoniae complex (Supplementary
Fig. 4). The GatD active site faces MurT with solvent and
substrate access in a cleft between both subunits (Fig. 3a).
The MurT cysteine-rich insertion. The central domain of MurT
compared to that of Mur ligases, comprises a 50 residue-long
cysteine-rich insertion (187–236) (Fig. 3b), with five cysteines in
S. pneumoniae, in positions 205, 208, 227, 230, and 232, of which
the first four are largely conserved. This cysteine tetrad is present
in Firmicutes with the exception of the Oenococcus,Weissella, and
Leuconostoc genera, where they are replaced by pairs of serine and
aspartate. The tetrad is also present in Cyanobacteria, Chloroflexi,
and some Actinobacteria.
The electron density map showed a great proximity of the
205, 208, 227, and 230 cysteine side chains. The best models
include two disulfide bonds, most likely between pairs 205–230
and 208–227 (Supplementary Fig. 5), although alternative
pairings cannot be ruled out. We found no evidence of a
coordinated metal ion.
The presence of these disulfide bonds is surprising, as MurT/
GatD functions in the cytoplasm where cysteines are reduced29.
We suspected that these bonds had formed during crystallization,
following the gradual depletion of the reducing agent. To
determine if disulfide bonds were present immediately after the
purification in reducing conditions, accessible thiols in MurT/
GatD or in a mutant (MT4C4S) with the four cysteines of the
disulfide bonds replaced by serines were alkylated by reaction
with iodoacetamide. The number of alkylations was determined
by mass spectrometry (Supplementary Fig. 6). The major species
exhibited six alkylations for wild-type MurT/GatD and two for
the MT4C4S variant, implying that the four thiols of the cysteine
tetrad were reduced and accessible after purification. As the thiols
of MTCys120 and MTCys325 are buried, the two other accessible
thiols likely belong to MTCys232 and MTCys417. Note that the
active site thiol of GatD was also alkylated.
When the PDB databank was searched for domains similar to the
inserted region, the best match was the N-terminal zinc-ribbon
domain of subunit RBN9 of the yeast RNA polymerase II (PDB#
3QT1 chain I30, Supplementary Fig. 5). Zinc-ribbons consist of a
three-stranded antiparallel β-sheet supporting two “knuckles”, each
carrying two cysteines that coordinate a Zn2+ cation31. The likeness
(main chain r.m.s.d. 1.22 Å over 29 residues) between the RNA
polymerase zinc-ribbon and the cysteine-rich insertion suggests that
the latter also binds zinc in vivo, raising the question of why zinc
was not found in our samples, despite the absence of chelators such
as EDTA during purification. It is possible that zinc has been
stripped by the high concentration of DTT as it chelates Zn2+
(KD ≈ 100 nM32).
That disulfide bonds are not required for catalysis was
confirmed by the residual activity exhibited in vitro by the
MT4C4S mutant (Table 2). However, the association with GatD
was impacted by the quadruple mutation, as the ratio of the
Coomassie-stained MurT/GatD bands after SDS-PAGE was 1.40,
instead of 1.78 for the wild type (Supplementary Fig. 7). Also, the
MT4C4S variant was degraded during storage at 4 °C. In vivo, the
quadruple mutation was not tolerated (Table 2), although another
mutant with lower in vitro activity was viable (GDY30A). It is
therefore likely that the protein is destabilized and its abundance
reduced in vivo.
MurT active site. Alignments of MurT and Mur ligases sequences
revealed residues conserved in the whole Mur family or in MurT
(Supplementary Fig. 8). To probe their importance, some residues
were substituted and the activity was evaluated in vitro. In most
cases, the conformation was likely unaffected as GatD was co-
purified with MurT in comparable amounts with a ratio of MurT/
GatD bands of 1.78 ± 0.15 (standard deviation). Partial digestion
with trypsin at 30 °C after the metal-affinity chromatography
resulted in similar fragment patterns for all active site variants,
indicating that conformation and stability were little affected
(Supplementary Fig. 9). GatD was resistant to digestion. The
35 kDa trypsin-resistant fragment of MurT could correspond to
the C-terminal part of the protein digested in the loop 135–143.
Interestingly, this part of the protein interacts with GatD, and
MurT in the absence GatD was fully degraded by trypsin. The
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Fig. 2 Enzyme kinetics of MurT/GatD. Reactions were performed at pH 7.5
and 30 °C in 50mM HEPES, 150mM NaCl, 10mM MgCl2, 2 mM TCEP and
1% DDM. The generation of ADP was followed by its phosphorylation by a
pyruvate kinase using phosphoenolpyruvate as phosphate donor. The
generated pyruvate was reduced into L-lactate by a lactate dehydrogenase
consuming NADH, which was followed by its absorbance at 340 nm. The
concentration of MurT/GatD, lipid II, ATP and L-Gln were 190 nM, 10 μM, 2
and 10mM, respectively, unless they were the varying component. a–c
Initial velocities for the reaction with varying concentrations of L-Gln, ATP
and lipid II, respectively. The solid curves represent the best fits to the data
of the Michelis-Menten equation (parameters apparent KM and Vmax are
given in Table 1). d Reaction progress curves with concentrations of lipid II
varying between 0 and 80 μM. The blue and red points are two
independent data sets (3% of the data points are shown). Solid curves
represent the best global fits to the two data sets of a Michaelis-Menten
model of the reaction (parameters apparent KD and kcat are given in Table 1)
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ability of some mutant MurT/GatD proteins to sustain growth of
S. pneumoniae was also tested (Table 2).
To analyze the active site of MurT, we superimposed its
structure with those of Mur ligases in complex with ligands
(MurC PDB# 1P3D, r.m.s.d. of 3.6 Å over 303 residues; MurD
PDB# 2UAG, r.m.s.d. of 4.4 Å over 290 residues; MurE PDB#
1E8C, r.m.s.d. of 3.7 Å over 292 residues; MurF PDB# 4CVM and
4QF5, r.m.s.ds of 3.7 and 4.7 Å over 316 and 309 residues,
respectively, the latter superimposition is shown in Fig. 5).
Models were also produced by computationally docking lipid II
together with ATP in the active site (Fig. 6). The list of residues
making contacts with the modeled substrates is given in
Supplementary Table 3.
The Mur ligase structures show ATP sandwiched between the
central and C-terminal domains and bound to the
mononucleotide-binding motif. In MurT, the deep cleft to
accommodate ATP is well defined and in the docking models
the nucleotide fills a position very similar to that in Mur ligases.
The substitution of MTLys59 of the P-loop (residues 52–60) by
alanine abolished the enzymatic activity, as observed with MurC6.
The primary amine of this lysine in MurC33 and MurF34 is
coordinated by the two distal phosphates of ATP (Fig. 5a), and
presumably plays a role in the transfer of the γ-phosphate to the
acceptor peptide. Since the crucial role of MTLys59 was
confirmed, the role of other conserved residues in ATP binding
can reasonably be inferred from the structures of MurC and
MurF, since the r.m.s.d. for residues of MurT and those of MurC
or MurF within 4.0 Å of the bound nucleotide is only 1.05 Å (89
atoms) and 0.98 Å (81 atoms), respectively.
MTGly58, MTThr60, and MTArg304 would interact with the α-
phosphate group (Fig. 5a). However, in apo-MurT, MTArg304
points away from the active site and the loop carrying this residue
would have to flip by nearly 180° to interact with ATP. As
conserved MTGly303 and MTArg304 form the hinge between the
central and C-terminal domains, it is conceivable that reorienta-
tion of the two domains upon substrate binding might reposition
MTArg304. MTGlu110 likely participates to ATP binding through
coordination of one Mg2+ ion, while asparagines 132, 270, and
273 probably interact with the adenine (Fig. 5). No electron
density was found in the ATP-binding pocket despite crystal-
lization with ATP, or soaking in cryo-protectant solutions
containing ATP.
Predictions of the binding mode of lipid II is more uncertain as
substrate binding to Mur ligases offers little guidance. Lipid II
lacks the uridine bound by the N-terminal domain of Mur ligases
that also makes contacts with the pyrophosphate. Instead, the
muropeptide-pyrophosphate of lipid II is anchored to the
membrane by an undecaprenyl chain. The N-terminal region of
MurT is mobile and not visible, precluding prediction of
interactions with the pyrophosphate of lipid II.
Docking calculations suggest that the acceptor peptide is held
against the loop connecting β2 and α2, which harbors the
conserved MTGly83-Ala84-Asn85 motif (Fig. 7). MTAsn85 is fully
conserved in MurT, but its position is poorly defined by the
density map (Fig. 5b). A fully conserved asparagine is also found
in MurD and MurF at the same position and the structures show
an interaction with the acceptor carboxylate of the substrate
peptide. Replacement of MTAsn85 by an alanine extinguished the
activity of MurT/GatD (Table 2).
MTAsp112 and MTGlu113 are conserved in MurT and MurC,
whereas they are replaced by a pair of serine residues in MurD
and MurE, or a glycine and a hydrophobic residue in MurF. In
MurC the two conserved acidic residues coordinate a Mg2+ ion
between ATP and the acceptor carboxylate33. This arrangement
was also found in the docking models. When the acidic residues
in positions 112 and 113 were replaced by serines, the activity was
lost, indicating that they could play an important role akin to that
in MurC. In all Mur ligases, the Mg2+ ion coordinated by
residues 112 and 113 and the acceptor carboxylate is also
coordinated by a conserved histidine in an active site loop. The
corresponding loop in MurT (135–143) that is not fully resolved
in the crystal structure contains six conserved residues but lacks a
histidine. Models gave no indication that residues of this loop
could coordinate a Mg2+ ion as the histidine of Mur ligases.
In the high score docking models, localization of the acceptor
peptide is consistent with its position in Mur ligases, but its
orientation is unclear (Fig. 6). While the acceptor carboxylate is
positioned close to the distal phosphate of ATP and a Mg2+ ion,
the peptide chain runs in various directions. The pose presented
in Fig. 6a is consistent with the substrate orientation in Mur
ligases, whereas the pose presented in Fig. 6b presents an opposite
orientation. The disaccharide has little or no interaction with the
protein, as observed for the MurNAc in Mur ligases. In the
computed models of the bound muropeptide, its lysine side chain
forms a salt bridge with the pyrophosphate. This is in contrast to
the situation in MurE where the ligand lysine is bridged to two
conserved acidic residues of the C-terminal domain35. In MurT,
the corresponding side of the catalytic cleft is devoid of acidic side
chain, precluding a similar binding of the substrate lysine.
ATP and lipid II docked on the central-domain of the crystal
structure do not interact with the C-terminal domain. Both
domains are known to move relative to each other in Mur
ligases26,36, and an acidic residue on a loop of the C-terminal
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Fig. 3 Domains of MurT/GatD. Ribbon representations of a the MurT/
GatD amidotransferase complex, b the central and c the C-terminal
domains of MurT. The glutamine substrate is shown as atom-colored
spheres. N- and C-termini, as well as numbering of α-helices and β-strands
are indicated. Domains are labeled and colored in dark cyan (central
domain), green (C-terminal domains), yellow (cysteine-rich zinc-ribbon-
like insertion) or pink (GatD)
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domain is hydrogen-bonded to the ATP ribose in the closed
conformation. The corresponding loop of MurT harbors three
consecutive conserved residues Lys321-Asn322-Pro323, and
MTAsn322 may contact the ATP ribose if the domains are
brought in proximity. Reorientation of the domains may occur
when the hinge MTArg304 interacts with ATP36.
GatD active site. The conserved residues GDCys107, GDHis206,
and GDAsp32 are in positions close to the Cys83-His193-Glu195
catalytic triad of the glutaminase of yeast IGP synthase37 (Fig. 4b),
identifying them as the probable catalytic residues. The corre-
sponding residues in S. aureus GatD are Cys94-His189-Glu19.
Glycine substitution of Cys94 in S. aureus GatD abolished amida-
tion of lipid II4, and substitution of either Cys94 or His189 by
alanine suppressed a residual glutaminase activity in the absence of
MurT38. The glutamate of the triad in canonical class I glutaminases
is highly conserved, two residues downstream of the catalytic his-
tidine in sequence, but its catalytic role is uncertain as its replace-
ment with a non-acidic residue had minor effect on the glutaminase
activity of the human γ-glutamyl hydrolase or the Escherichia coli
carbamoyl phosphate synthase39,40. Whereas GDAsp32 in S. pneu-
moniae GatD occupies a spatial position similar to the glutamate of
the glutaminase triad, Asp19 in S. aureus GatD has a different
orientation (Fig. 4c). This aspartate is at the junction between helix
α1 and a loop joining strand β2. In S. pneumoniae GatD, this loop
interacts with helix η8 of MurT. As S. aureus GatD was crystallized
without MurT, the loop and Asp19 may have a non-native con-
formation. In T. maritima IGP synthase, Asp98 of the synthase
subunit contributes to the glutaminase activity25. In MurT/GatD,
MTAsp355 points towards GatD active site in an position analogous
to Asp98 in the IGP synthase. However, unlike in the latter
enzyme25, when MTAsp355 was replaced by an alanine, the activity
was reduced but not suppressed (Table 2). The conserved GDGly72-
Gly73-Gly74 likely provide the oxyanion hole, which is common to
many hydrolases41.
After complete building of GatD in the electron density map,
an elongated residual density was present in the vicinity of
GDCys107 and occupied a volume that matched the position of
the glutamine substrate in T. maritima IGP synthase25. Although
no glutamine was added for crystallization, this compound could
have been trapped while the protein was produced in E. coli;
glutamine was thus tentatively placed in the residual density
observed in GatD active site (Fig. 4).
Conserved GDArg142 at the extremity of the catalytic cleft
opposite GDCys107 appears to interact with the glutamine substrate.
The corresponding Arg128 in S. aureus GatD was found to interact
with a glutamine outside of the active site, and its replacement by an
alanine abrogated glutaminase activity38. The two structures
support a model in which the side chain of GDArg142 helps to
“capture” the substrate from the solution (Fig. 4c).
MurT/GatD interface. The MurT/GatD complex buries 1231
Å2 of solvent-accessible area, which is typical of enzymatic
complexes42. The MurT loop 135–143, including the unre-
solved stretch 137–141, is at the interface with GatD in a
position where it could connect the central and C-terminal
domains and form a channel to conduct ammonia to the
acceptor peptide. Individual replacement by alanine of four
conserved charged residues of the loop had contrasting con-
sequences. Whereas side chain ablation of MTAsp136 and
MTArg140 reduced the enzymatic activity, that of MTAsp139
and MTGlu143 had minor effects. Although none of these
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Fig. 4 Structure of GatD. a Ribbon representation of GatD from S. pneumoniae with numbering of α-helices and β-strands. The putative glutamine molecule
is shown as atom-colored spheres. N- and C-termini are indicated. b Superimposition of the active sites of GatD from S. pneumoniae (GatDSpn, in pink) and
of the glutaminase HisH from S. cerevisiae (HisHSce, in light grey, PDB#1JVN). The glutamine and the active site residues from GatDSpn are labeled and
shown as atom-colored sticks. c Superimposition of the active sites of S. pneumoniae GatD (in pink) and of GatD from S. aureus (GatDSau, in dark grey, PDB#
5N9M). The glutamine and active site residues are shown as sticks, the numbering is that of S. pneumoniae
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substitutions changed the susceptibility to trypsin (Supple-
mentary Fig. 9), the MTD136A and MTD139A substitutions
impacted the interaction with GatD, as indicated by the mod-
ified ratio of purified MurT/GatD (Supplementary Fig. 7),
complicating the interpretation of the enzymatic data.
Facing GatD, an opening in MurT is surrounded by negative
charges provided by MTGlu201, MTAsp355, and MTAsp361.
Flanking this negative gate is the positive charge of conserved
MTArg135, which forms a bridge with MTGlu201 (Fig. 7a and
Supplementary Figs 10 and 11). On the same side of the opening, a
hydrophobic patch is formed by residues of the cysteine-rich
insertion: MTTyr198, MTIle203, MTLeu204, MTIle211 (Fig. 7b). This
hydrophobic surface is matched on GatD by a patch formed by
GDLeu6, Cα and Cβ of GDAsn25, GDLeu26, GDIle36, GDIle54,
GDLeu57, and GDPhe77. Another hydrophobic patch of MurT
formed by MTTrp360 and MTVal391 on the other side of the
negative gate is facing a corresponding patch on GatD formed by
GDGly34, GDMet38, GDTyr41, and GDPro208 (Fig. 7b and
Supplementary Figs 10 and 11). Lining this neutral patch and
completing the interface, MTArg387 and MTArg390 make coulom-
bic interaction with GDGlu245.
Residues of the hydrophobic interacting surfaces are not
conserved with the exception of the pair MTTrp360 and GDGly34,
which are in direct contact. Ablation of the indole rings by the
MTW360A substitution abolished the interaction as GatD could
not be co-purified with MurT (Supplementary Fig. 12). The
resulting lone MurT protein was more susceptible to tryptic
digestion than in the complex (Supplementary Fig. 9). This
destabilization may result from the loss of interaction with GatD
or directly from the absence of the indole ring, or from a
combination of these intramolecular and intermolecular effects.
The GatD active site does not communicate directly with the
opening in MurT. The passage is blocked by residues GDAsn28-
Thr29-Tyr30 (Supplementary Fig. 10), with GDTyr30 in a
position analogous to that of Tyr136 in T. maritima IGP
synthase, where it plugs the entrance of the ammonia channel25.
Substitution of Tyr136 by an alanine in IGP synthase uncoupled
the glutaminase and synthase but preserved the overall activity25.
In contrast, the GDY30A substitution severly reduced the MurT/
GatD activity in vitro although it was tolerated in vivo (Table 2).
Viability of MurT/GatD point mutants. Different mutTgatD
alleles were introduced at the native locus in a strain containing
an ectopic copy of the operon. Deletion of the ectopic copy was
then attempted. Only the wild type and GDY30A were tolerated,
despite the fact that the GDY30A variant had a lower in vitro
activity than other variants (Table 2). If less than 10% MurT/
GatD activity is sufficient for growth, as implied by the viability of
the GDY30A substitution, the lethality of the MTD355A and
MT4C4S variants, which exhibit higher in vitro activity, may result
from a lower stability in vivo or from disruption of other cellular
interactions.
Table 2 Comparison of the activity and ability to sustain
growth of MurT/GatD variants
Variant Relative activity (%) Viability
WT 100 +
MTK59A 2 ± 1 -
MTN85A 1 ± 1 -
MTD112S/E113S 3 ± 2 -
MTD136A 10 ± 4 n.d.
MTD139A 71 ± 11 n.d
MTR140A 13 ± 5 n.d
MTE143A 102 ± 30 n.d
MT4C4S 23 ± 10 -
MTD355A 28 ± 10 -
GDY30A 7 ± 3 +
Relative activities are given as percentage of that of WT. Unless specified, substitutions were in
MurT. The mean of three independent experiments is given with the standard deviation.
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Fig. 5 The active site of MurT. a Superimposition of the active sites of MurT
from S. pneumoniae and MurF from Acinetobacter baumannii (PDB# 4QF5,
ATP-bound form of MurF). The central domains of MurT and MurF are
colored in dark cyan and light grey, respectively. The C-terminal domains of
MurT and MurF are colored in green and dark grey, respectively. The bound
ATP in MurF active site is shown as atom-colored sticks and Mg2+ ions as
green spheres. b Ribbon representation of MurT active site with putative
positioning of ATP, Mg2+, and MurNac tripeptide inferred from substrate-
bound forms of MurF (PDB# 4QF5 and 4CVK). The ATP, Mg2+, and the
MurNac tripeptide are shown as orange, green and grey spheres,
respectively. MurT residues predicted to interact with the substrates are
labeled and shown as atom-colored sticks
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Discussion
The essentiality of MurT/GatD is thought to result from the
optimal transpeptidase activity of PBPs with amidated stem-
peptides11. As predicted, depletion of MurT/GatD reduced the
amount of cross-linked muropeptides (Supplementary Table 1).
Reduced cross-linking could lead to reduced O-acetylation43,
which could in turn increase susceptibility to lysozyme44.
The increase in branched peptides following depletion of MurT/
GatD was unexpected. Non-amidated lipid II could be a better
substrate for the MurM enzyme, thus inducing a balance between
amidation and branching. However, as depletion of PBP2b also
causes a surge in branched muropeptides45, we favor a more
general explanation where branching is a phenotypic adaptation
that compensate for a weaker cell wall. This adaptation could
result from a greater availability of lipid II for MurM if its flow to
the cell surface is reduced by the MurT or PBP2b depletion. This
adaptation, however, is insufficient to rescue cells completely
devoid of MurT/GatD, which remains an attractive drug target.
The limited resolution and absence of ligand leave a number of
interrogation open for speculation. Of particular interest is the
conformation of the loop 135–141. Two modeling resulted in
markedly different conformation. In a model generated by
SWISS-MODEL46 followed by energy minimization with
YASARA47, the structure remained very close to the input crystal
a
b
Fig. 6 Models of the substrates ATP and lipid II docked in MurT active site.
Representative poses of the two best score dockings are shown (a, b). The
color scheme of MurT/GatD is as in Fig. 3. ATP is in cyan with the
phosphates in orange. For docking, a lipid II variant was used with the
undecaprenol replaced by ethanol to avoid non-specific hydrophobic
interaction. The disaccharide and ethanol are in white, the pentapeptide is
in magenta except the D-glutamate in yellow. Mg2+ ions are shown as
green spheres
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Fig. 7 Interface of the MurT/GatD complex. a View of the negative gate of
MurT facing the GatD active site seen from the MurT active site. MurT
residues bordering the putative channel for the transfer of ammonia are
labeled and shown as atom-colored sticks. The GDCys107-GDHis206-
GDAsp32 residues of the GatD active site are shown as sticks without
labels. Other residues involved in the MurT/GatD interface are shown as
atom-colored lines. The dashed line indicate the 137–143 loop missing from
the structure of MurT. L-glutamine is shown as spheres. b View of the
MurT/GatD interface with the residues involved in hydrophobic
interactions labeled and shown as atom-colored sticks. The main chains of
the proteins are shown as loops and the residues involved in electrostatic
interactions are shown in atom-colored lines
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structure. In this model, the loop forms one side of the negative
gate of MurT (Supplementary Fig. 10). MTAsp136 and MTAsp139
interact with MTArg140. In another model generated with Dis-
covery Studio, the structure was more affected with many rear-
ranged side chains. In this model, MurT shows no tunnel
entrance (Supplementary Fig. 10), but MTArg140 protrudes inside
GatD active site and MTArg135 closes the gate, while MTAsp136
forms a salt bridge with MTLys321. These models could represent
different conformations accessible to the flexible loop.
The opening in MurT facing the active site of GatD commu-
nicates with a network of cavities inside MurT (Fig. 8). One branch
is formed within the central domain between the Zinc-ribbon-like
insertion and helix α2, another branch is extended between helix α7
of the C-terminal domain and the Zinc-ribbon-like region. These
two branches may be obstructed by the reorientation of the
domains. A third channel reaches into the MurT active site and
likely serves to transfer ammonia generated by GatD. Escape of
ammonia could be prevented by narrowing of the active site and the
C-terminal domain contacting the substrates.
The hypotheses about substrate binding, loop conformation
and domain movement await the determination of structures
with bound ligands. The stabilizing role of zinc in the cysteine-
rich region also require further investigation. The structure pre-
sented here will be invaluable in these endeavors, while substrate
analogues and known inhibitors of Mur ligases will be tested to
initiate a search for antibacterials aimed at the major pathogens S.
pneumoniae, S. aureus, and M. tuberculosis.
Methods
Construction of a MurT/GatD depletion strain. Pneumococcal strains used and
produced are listed in Supplementary Table 4. Depletion of MurT/GatD was
performed by using the ComRS gene depletion system48. The strain SPH131
contains a replaceable Janus cassette behind the ComS-inducible PcomX promoter of
the ComRS system. This Janus cassette was substituted with the murTgatD genes
by transforming SPH131 with an amplicon comprising the operon fused with the
1000 bp regions flanking the Janus, giving rise to strain SPH476. This amplicon was
constructed by amplifying the murTgatD operon from strain RH1 using the pri-
mers ds188 and ds189 (Supplementary Table 5). The Janus upstream and down-
stream regions were amplified using pairs khb31/khb36 and khb33/khb34. The
three fragments were joined by overlap extension PCR49. Next, the native murT-
gatD operon in strain SPH476 was deleted by replacement with a Janus cassette.
DNA fragments corresponding to the 1000 bp regions upstream and downstream
of the native operon were amplified using pairs ds190/ds191 and ds192/ds193,
respectively. Janus was amplified from strain SPH131 with the primer pair
Kan484F/RpsL41R. The three PCR-products were fused by overlap extension PCR.
The resulting amplicon was transformed into strain SPH476 generating strain
SPH477, which required 0.2 µM ComS in the growth medium to drive ectopic
expression of murTgatD. The Janus in the SPH477 genome was removed by
transforming this strain with a DNA amplicon corresponding to the 1000 bp
regions upstream and downstream of the native murTgatD. These fragments were
amplified from RH1 using the pairs ds190/ds195 and ds193/ds194, and joined by
overlap extension PCR. The resulting strain, SPH478, required 0.2 µM ComS in the
growth medium.
Depletion of MurT/GatD and cell wall isolation. For isolation of cell wall
material from MurT/GatD-depleted cells, strain SPH478 was first grown in 5 mL C
medium to an OD550= 0.35 in the presence of 0.2 μM ComS. Then, the cells were
washed once with 5 mL ComS-free C medium before they were transferred to a
bottle containing 1 L of ComS-free C medium. Cells were incubated at 37 °C, and
growth was monitored at OD550 every 30 min. When growth levelled out because
of MurT/GatD depletion (OD550 ≈ 0.4), cells were collected at 5000 g for 10 min.
Cell wall material was isolated and analyzed as follows50. The cell pellet from 2 L of
culture was resuspended in 40 mL of ice-cold 50 mM TrisHCl (pH 7.0) and added
dropwise to 150 mL of boiling 5% sodium dodecyl sulfate (SDS). After boiling for
another 30 min, the suspension was centrifuged 45 min at 130,000 g and 25 °C.
Following two washes with 30 mL of 1M NaCl and repeated washes with water
until free of SDS, the pellet was resuspended in 2–4 mL of water, one-third volume
of acid-washed glass beads (0.17–0.18 mm diameter, Sigma) was added to disrupt
cells in a FastPrep machine (FP120, Thermo Scientific). After filtration to remove
glass beads, and clarification with a 5 min centrifugation at 10,000 g, the super-
natant was centrifuged for 45 min at 130,000 g and 25 °C. The pellet was resus-
pended and stirred for 2 h at 37 °C in 20 ml of 100 mM TrisHCl (pH 7.5), 20 mM
MgSO4, 10 μg mL−1 DNase A and 50 μg mL−1 RNase I, prior to addition of 10 mM
CaCl2 and 100 μg mL−1 trypsin and further incubation overnight at 37 °C, and
enzymes were inactivated 15 min at 80 °C with 1% SDS. Cell wall was centrifuged
for 45 min at 130,000 g at 25 °C, resuspended in 20 mL of 8M LiCl, and incubated
for 15 min at 37 °C. The procedure was repeated with 10 mM ethylenediaminete-
traacetic acid (EDTA, pH 7.0). Cell wall was washed with water, acetone, and water
before resuspension in 2–4 mL of water and lyophilization. To remove teichoic
acids, 5 mg of cell wall was stirred with 48% hydrofluoric acid (HF) for two days at
4 °C. Peptidoglycan was centrifuged (45 min, 130,000 g, 4 °C), washed with water,
100 mM TrisHCl (pH 7.0), and twice with water. Peptidoglycan (0.5 mg in 200 μL)
was digested with 10 μg of cellosyl in 20 mM sodium phosphate (pH 4.8) for 24 h at
37 °C. The reaction was stopped by heating at 100 °C for 10 min prior to cen-
trifugation for 10 min at 13,000 g to clarify the solution. An equivalent volume of
500 mM sodium borate (pH 9.0) and a few crystals of NaBH4 were added and
incubated 30 min at 20 °C to reduce saccharrides, and the reaction was stopped
lowering the pH to 4.0 with H3PO4. Muropeptides were analyzed by reversed-phase
HPLC using a Prontosil 120–3-C18-AQ (250 4.6 mm, 3 μM) column on an Agilent
1100 system. The separation was obtained with a linear 135-min gradient from 0 to
30% methanol in 10 mM sodium phosphate (pH 6.0) and the column temperature
was 55 °C. The muropeptides were quantified by their peak area.
Electron microscopy. To prepare MurT/GatD-depleted cells for morphological
examination, strain SPH478 was grown in 5 mL C-medium containing 0.2 µM
ComS to an OD550= 0.2. Then the cells were washed once with 5 mL ComS-free
C-medium and diluted to OD550= 0.01 in 5 mL C-medium containing 0.2 µM,
2.5 nM or 1.5 nM ComS. When the cell cultures reached OD550= 0.3, the cells were
harvested at 4000 g and diluted to OD550= 0.01 in 10 mL fresh C-medium con-
taining the same concentrations of ComS as described above. Cultures reaching
OD550= 0.3 were harvested at 4000 g for 5 min. Cells were washed once with ice
cold PBS before they were fixed and prepared for scanning and transmission
electron microscopy (SEM and TEM) as follows51. For SEM, cells were dehydrated
with 70 and 90% ethanol for 10 min each and then with 100% ethanol overnight,
a b
Fig. 8 Putative channels allowing the transfer of ammonia inside MurT. Front (a) and back (b) view with the zinc-ribbon-like region removed to allow better
view. The color scheme of the domains is as in Fig. 3. The modeled loop 137–141 is shown in blue. The glutamine in the GatD active site is shown as atom-
colored spheres. The cavity surface is in transparent gray with a possible path of the ammonia in pink
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and subjected to critical point drying with liquid CO2. Samples were coated with
Au-Pd and examined with a Zeiss EVO 50 EP scanning electron microscope. For
TEM, fixed cells were post-fixed for 1 h at room temperature using 1% OsO4 (w/v)
and 1.5% K3[Fe(CN)6] (w/v) dissolved in water. Following three washing steps in
water, cells were pre-stained for 30 min with 1% uranyl acetate. Next, cells were
washed for three times in water and dehydrated with sequential 10-min incuba-
tions in 70, 90, and 100% ethanol. Finally, cells were stepwise infiltrated in LR
White resin as follows: LR White resin: EtOH in ratios 1:3 for 30 min, 1:1 overnight
and 3:1 for 4 h, and finally 100% LR White resin overnight followed by embedding
in 100% LR White resin at 60 °C overnight. Thin sections were cut with a diamond
knife mounted on an ultra-microtome (Leica, EM UC 6). The sections were
counterstained with 1% KMnO4 for 10 min. After staining, grids were washed
thoroughly in water. The sections were examined under a FEI MORGAGNI 268
electron microscope.
Site-directed mutagenesis. Site-directed mutagenesis for the recombinant pro-
duction of point mutants of MurT/GatD were performed on double-stranded
expression plasmids using primers with the desired mutations (Supplementary
Table 5)52. Site-directed mutagenesis for expression of MurT/GatD in S. pneu-
moniae was performed by using overlap extension PCR with primers containing
the desired mutations (Supplementary Table 5). The complementary forward and
reverse primers annealing internally in the murT or gatD genes were used in
combination with the primers ds190 and ds193, which bind 1000 bp upstream and
downstream of murTgatD. Point mutated versions of the murTgatD operon were
introduced into the S. pneumoniae genome by replacement of the Janus cassette in
strain SPH477. The ectopic copy of murTgatD behind PcomX was then deleted by
replacement with a Janus cassette amplified from strain SPH131 using the primer
pair khb31/khb34. If the point mutation in murTgatD was not tolerated, the
ectopic murTgatD could not be deleted.
Production of MurT/GatD. The complex was expressed from a modified pET-30
plasmid to allow co-expression in E. coli BL21 Star™ (DE3) of MurT with a N-
terminal poly-histidine-tag and GatD without tag. After growth in Luria broth to
saturation, expression was induced overnight at 20 °C by the addition of 0.5 mM
IPTG. Cells were resuspended in 50mM HEPES, pH 7.5, 300mM NaCl, 10mM
MgCl2, 25 mM imidazole, 2 mM TCEP, and Complete™ protease inhibitors. After
cell breakage with a Microfluidizer M−110P (Microfluidics) and removal of cellular
debris and membranes by ultracentrifugation, the lysate was loaded onto a 1 mL
HisTrap FF column (GE Healthcare) and proteins were eluted with imidazole
concentration steps at 50, 100 and 200mM. Fractions of the 100mM imidazole step
were pooled and diluted 10-fold in the same buffer without NaCl, imidazole or
TCEP but with 5mM DTT, and loaded onto a 8 mL Q Sepharose column (GE
Healthcare). Proteins were eluted with a 150–450mM NaCl gradient over 70 mL.
After concentration using Amicon® Ultra-4 cells with a 30k cutoff, proteins were
further purified by size-exclusion chromatography on an ENrich™ SEC650 column
(BioRad) equilibrated with 50mM HEPES, pH 7.5, 150mM NaCl and 10mM
MgCl2, 2 mM DTT. For crystallization, the complex was concentrated again to more
than 50mg mL−1. Concentration was determined by measuring the absorbance at
280 nm with the extinction coefficient ε280= 63,860 M−1 cm−1 (0.788 mg-1 mL
cm−1). For activity measurements of the wild type and mutant proteins, the anion
exchange chromatography was omitted and the final buffer contained 2 mM TCEP
instead of DTT.
Structure determination. Crystallization trials on the native MurT/GatD complex
were performed in 96-well Greiner Crystal Quick plates with 100 nL protein (6 mg
mL−1) and 100 nL reservoir solution. Native MurT/GatD crystallized in 0.2 M tri-
ammonium or tri-sodium citrate buffers, pH 6.0–8.2, 20% PEG 3350 at 20 °C in
24–48 h. Crystallization conditions were manually refined and large native crystals
were finally obtained in 0.2 M tri-sodium citrate pH 6.1, 14% PEG 3350, 4 mM
NiSO4. Native MurT/GatD crystals were cryoprotected by transfer into 0.2 M Tri-
sodium citrate pH 6.1, 16% PEG 3350, 4 mM NiSO4, 20% glycerol, and then flash-
frozen in liquid nitrogen. Seleno-methionine (SeMet) derivatives of MurT/GatD
crystals were obtained in 0.2 M Tri-sodium citrate pH 6.2, 15% PEG 3350 and were
cryoprotected by exchanging the mother liquor with crystallization solution con-
taining 20% glycerol, and flash-frozen in liquid nitrogen. Native and SeMet MurT/
GatD crystals crystallized in the space group R3 with isomorphous unit cell
parameters (Supplementary Table 2). Native diffraction data were collected on the
automated ID30a-1 beamline of the European Synchrotron Radiation Facility
(ESRF, Grenoble, France). Single-wavelength anomalous diffraction (SAD) data
were collected on the BM30A-FIP beamline at ESRF. The diffraction data were
reduced by using XDS53 and phase determination was achieved using the SIRAS
(Single Isomorphous Replacement with Anomalous Scattering) method, including
a heavy-atom search with SHELXD54, followed by phasing with SHARP55 and
density modification with SOLOMON56. All calculations were performed auto-
matically using the autoSHARP package57. After automated model building using
PHENIX58, the crystallographic model was refined by using REFMAC559 in the
CCP4 package, iterated with manual building. Water, ion and glutamine molecules
were added manually in COOT60. Model quality was determined by using PRO-
CHECK61, with all residues within most favorable or allowed regions of the
Ramachandran plot. The data collection and refinement statistics are summarized
in Supplementary Table 2).
Enzymatic assay. The activity of MurT/GatD was monitored through its hydrolysis
of ATP. A classical ATPase assay was used where ADP is phosphorylated by pyr-
uvate kinase from phosphoenolpyruvate, pyruvate being reduced to L-lactate by
lactate dehydrogenase consuming NADH, which is followed by its absorbance at
340 nm62. For the determination of the enzymatic parameters, 10 μL of the substrate
under investigation (lipid II, ATP or L-Gln) at 10-fold the final concentration in
50 mM HEPES, pH 7.5, 150mM NaCl and 10 mM MgCl2 were placed in a 1 cm
quartz cuvette prior to the addition at time t= 0 of 90 μL of the reaction mix (minus
the substrate being studied) in the same buffer to reach the following final con-
centrations: 250 μM NADH, 1mM potassium phosphoenolpyruvate, 25 μg mL−1 L-
lactate dehydrogenase (porcine, Roche Diagnostics), 50 μg.mL-1 pyruvate kinase
(rabbit, Roche Diagnostics), 2 mM TCEP, 1% n-dodecyl-β-D-maltoside (DDM,
Anatrace), 190 nM MurT/GatD, 10 μM lipid II, 2 mM ATP and 10mM L-Gln. The
absorbance at 340 nm was recorded at 30 °C with a thermostated Uvikon 943
double beam spectrophotometer (Kontron Instruments). When investigating the
activity of MurT/GatD mutants, 10 μL of lipid II and 40 μL of MurT/GatD variant
were placed in the cuvette prior to the addition of 50 μL of reaction mix to reach the
same final concentrations stated above, except lipid II at 20 μM. The amounts of
NADH, potassium phosphoenolpyruvate, L-lactate dehydrogenase and pyruvate
kinase were checked to be non-limiting.
Initial velocities (Vi) were measured by linear fitting of the reaction progress
curves at early time points using the extinction coefficient of NADH at 340 nm ε=
6300M−1cm−1. The apparent KM and Vmax were extracted from non-linear fitting
of the Vi at different substrate concentrations [S] to the Michaelis-Menten equation
Vi= [S]Vmax/(KM+ [S]). Fittings were performed using the Kaleidagraph
(Synergy) software. Alternatively, the complete progress curves were collectively
fitted to a Michaelis-Menten model of the reaction to extract the apparent KD and
kcat using the Dynafit software (Biokin)63.
Thiol counting. The number of accessible free thiols was determined by alkylation
under native condition of wild-type and 4C4S MurT/GatD and mass spectrometry
analysis. One fourth-volume of 0.5 M iodoacetamide in 1.5 M Tris HCl pH 8.8
were added to the purified proteins for 5 min at room temperature prior to
desalting on G-25 Sephadex resin (NAP-5 column, GE Healthcare) in 50 mM
ammonium acetate pH 7. Samples were analyzed by electrospray mass
spectrometry.
Docking. Calculations were performed in BIOVIA Discovery Studio 4.5 (Accelrys).
The structure of MurT/GatD was cleaned, side-chain conformations were opti-
mized for residues with inserted atoms, missing loops were modeled based on
SEQRES information, and the protonation state was predicted at pH 7.5 (Prepare
Protein protocol of DS 4.5). CDOCKER64 was used to dock flexible ligands onto
the rigid protein.
To propare ligands, canonical tautomers were generated, keeping the largest
fragments, standard charges of common functional groups were used, kekule
structures were generated, ionization states at a given pH range and tautomers were
enumerated (Prepared Ligand protocol of DS 4.5). Reasonable 3D conformations
were created using Catalyst. High-temperature molecular dynamics were used to
generate random ligand conformations from the initial ligand structure. Due to the
high flexibility of lipid II, several conformations generated with the BEST
algorithm65 were docked to cover the full range of conformers. The lowest energy
poses were retained and clustered according to their binding mode and the
interaction with key residues. Snapshots of the docked ligands were generated using
BIOVIA DS Visualizer.
Data availability. Coordinates and structure factors have been deposited in the
Protein Data Bank, with Accession No. 6FQB [https://doi.org/10.2210/pdb6FQB/
pdb]. The data that support the findings of this study are available from the
corresponding author upon request.
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